Tuesday, 18 August 2020 / 13:00 CEST
Controlled Human Infection Challenge Studies involve the deliberate infection of healthy volunteers to support clinical vaccine development, for example for malaria. This webinar will discuss ethical and scientific principles for such studies, outline the risk mitigation steps taken in previous malaria human challenge studies, explore how this might be applied in the context of COVID-19 vaccine development, and address ethical and practical concerns.
Accessing the live-streamed event is free, but we ask that you register.
- Euzebiusz Jamrozik, Monash Bioethics Centre, Monash University, Melbourne, Australia
- Katherine Littler, Global Health Ethics Team, World Health Organization, Geneva, Switzerland
- Colin Pillai, CP+ Associates and Pharmacometrics Africa, Basel (Switzerland) and Cape Town (South Africa)
- Bernd Rosenkranz, Fundisa African Academy of Medicines Development NPC, Schwielowsee (Germany) and Cape Town (South Africa)
- Getnet Yimer, Regional Director for Global One Health Initiative of the Ohio States University in East Africa, Addis Ababa, Ethiopia
- Claudia I. Emerson, Director, Institute on Ethics & Policy for Innovation, McMaster University, Hamilton, Canada